Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by beechguyon Jun 14, 2013 10:21am
175 Views
Post# 21524943

RE: How I see this playing out.

RE: How I see this playing out.

Sorry restating the last paragraph. We should be getting around 50 to 80mm in up front Urocidin payments for the world. (we got 38mm last time with only phase 2 in the books) After paying out the Paladin debt we should have 20 to 50mm in cash. After selling the VMC for 50 to 80mm (as I am told it is worth with GMP), we should have 45 to 105mm in cash and we still own Urocidin and AH. At that point they can sell Urocidin outright  for 150mm?? Giving us somewhere around 1.95 to 2.55 a share in cash with a growing AH business.

 

Not sure why we have to sell AH. Just get lean and sell the VMC. Something the current administration finds impossible to comprehend. GL

 

beech

<< Previous
Bullboard Posts
Next >>